ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Ethics Commission Backs Limited Pilot Program for Compensation Of Injured Research Subjects

January 16, 1981

Hudis’s Address At ASCO 2014: On Value & Commitment

June 6, 2014

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988

Duke, M.D. Anderson Receive Bristol-Myers Unrestricted Grants

May 5, 1989

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003